V

vTv Therapeutics
D

VTVT

14.360
USD
-0.89
(-5.84%)
Market Closed
Volume
76
EPS
-0
Div Yield
-
P/E
-3
Market Cap
37,512,011
OverviewSignalsIdeasNews
Related Instruments
    A
    ACST
    0
    (0%)
    0.000000 USD
    B
    BHVN
    -4.260
    (-8.76%)
    44.390 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    E
    EOLS
    0.220
    (1.85%)
    12.110 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    O
    OMER
    -0.19000
    (-2.73%)
    6.76000 USD
    S
    SAGE
    -0.26000
    (-4.84%)
    5.11000 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    V
    VBIV
    0
    (0%)
    0.000000 USD
    More
News

Title: vTv Therapeutics

Sector: Healthcare
Industry: Biotechnology
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.